← Back to Search

Procedure

Totally Robotic for Lung Cancer

N/A

Waitlist Available

Led By Waël C Hanna, MDCM, MBA, FRCSC

Research Sponsored by St. Joseph's Healthcare Hamilton

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 weeks post-surgery

Awards & highlights

Study Summary

This trial compares the costs and patient outcomes of using robotic technology in lung cancer surgery. The study will evaluate whether performing the surgery totally robotically or with assistance from a bedside surgeon is more effective and cost

Who is the study for?

This trial is for patients with early-stage non-small cell lung cancer (NSCLC). Participants should be suitable candidates for robotic-assisted thoracoscopic surgery (RTS) but have not yet undergone the procedure. Specific eligibility criteria are not provided, so it's important to consult with the study team for detailed requirements.Check my eligibility

What is being tested?

The trial compares two methods of performing RTS: Totally Robotic lung resection using Vessel Sealer Extend and SureForm staplers versus Surgeon-Assisted resection using Medtronic Signia stapler. The goal is to assess differences in costs and patient outcomes between these techniques during NSCLC surgery.See study design

What are the potential side effects?

While specific side effects are not listed, surgical procedures like RTS may include risks such as bleeding, infection, pain at the incision site, complications related to anesthesia, and potential damage to surrounding tissues or organs.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 weeks post-surgery

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 weeks post-surgery

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 weeks post-surgery for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Costs of Totally Robotic versus Surgeon-Assisted Robotic Lung Resection

Secondary outcome measures

Duration of Chest Tube

Intraoperative Complications and Adverse events (AEs)

Length of Stay in Hospital

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Totally RoboticExperimental Treatment1 Intervention

Patients randomized to this arm will undergo RTS with the Da Vinci Vessel Sealer Extend Energy Device and SureForm Stapler.

Group II: Surgeon-AssistedActive Control1 Intervention

Patients randomized to this arm will undergo RTS with the Medtronic Signia Stapler.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

St. Joseph's Healthcare HamiltonLead Sponsor

196 Previous Clinical Trials

25,424 Total Patients Enrolled

Waël C Hanna, MDCM, MBA, FRCSCPrincipal InvestigatorSt. Joseph's Healthcare Hamilton

4 Previous Clinical Trials

742 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research include individuals who are older than 80 years old?

"Recruitment is open for individuals beyond 18 years old, yet below the age of 120."

Answered by AI

Is the enrollment for this medical study still open to new participants?

"According to information on clinicaltrials.gov, recruitment for this specific trial is currently closed. The study was initially listed on April 1st, 2024 and the last update occurred on March 28th, 2024. Despite this trial not actively recruiting participants anymore, there are approximately 1624 other opportunities available for interested candidates at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC

Wael Hanna 2024. "Totally Robotic Versus Surgeon-Assisted Robotic Lung Resection For Early-Stage NSCLC". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06348030.